---
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263213016.md"
description: "The innovative drug concept surged in the afternoon, with Nossan hitting the 20% limit up, followed by gains in PR, Tigermed, Jiuzhou Pharma, and Highfine"
datetime: "2025-10-29T05:15:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263213016.md)
  - [en](https://longbridge.com/en/news/263213016.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263213016.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263213016.md) | [English](https://longbridge.com/en/news/263213016.md)


# 

The concept of innovative drugs fluctuated and surged in the afternoon, with Nossan reaching a 20% limit up, and PR, Tigermed, Jiuzhou Pharma, and Highfine following suit

### 相關股票

- [PR (301230.CN)](https://longbridge.com/zh-HK/quote/301230.CN.md)
- [Tigermed (300347.CN)](https://longbridge.com/zh-HK/quote/300347.CN.md)
- [TIGERMED (03347.HK)](https://longbridge.com/zh-HK/quote/03347.HK.md)
- [Jiuzhou Pharma (603456.CN)](https://longbridge.com/zh-HK/quote/603456.CN.md)
- [Highfine (301393.CN)](https://longbridge.com/zh-HK/quote/301393.CN.md)

## 相關資訊與研究

- [Know a rising star in pharma marketing? Nominate them here](https://longbridge.com/zh-HK/news/278461777.md)
- [InnoScience Added to FTSE Global Equity Index Series](https://longbridge.com/zh-HK/news/278489954.md)
- [US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms](https://longbridge.com/zh-HK/news/278592116.md)
- [Sightview Unveils Fresh Patient Engagement Tools at Vision Expo 2026](https://longbridge.com/zh-HK/news/278585570.md)
- [India, Uzbekistan launch pharma-nutra corridor; focus on Eurasian market](https://longbridge.com/zh-HK/news/278403584.md)